CENTESA
associated with 32 other trademarks
House mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditi...

Words that describe this trademark:

mitochondrial diseases  house mark  mark pharmaceuticals  cardiovascular diseases  diseases disorders  treatment  pharmaceuticals  disorders  conditions 

Serial Number:

88580529

Mark:

CENTESA

Status:

Cancellation Pending

Status Date:

06-17-2024

Filing Date:

Registration Number:

6325129

Registration Date:

04-20-2021

Goods and Services:

House mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

02-02-2021

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

PARC SCIENTIFIQUE EPFL, PSE-C

Correspondent Name:

Recent Trademark filings by this company